Wang Xiaogang, Zhang Huiwen, Xu Mingkai, Cai Yongming, Liu Changxiao, Su Zhencheng, Zhang Chenggang
Graduate University of the Chinese Academy of Sciences, Beijing 100039, PR China.
Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang 110016, PR China.
Microbiology (Reading). 2009 Mar;155(Pt 3):680-686. doi: 10.1099/mic.0.025254-0.
The bacterial toxin staphylococcal enterotoxin C2 (SEC2) can cause staphylococcal toxic shock syndrome and food poisoning. Although the previously determined crystal structure of SEC2 revealed that some histidine residues (His47, His118 and His122) contribute to the binding of zinc ions, little is known about their biological roles in SEC2. This prompted us to investigate the role of the zinc site coordinating histidine residues in the biological activities of SEC2. The mutants with substitutions at positions 118 and 122 all retained T-cell stimulatory activity, whereas the histidine mutants at position 47 were defective in the ability to stimulate T-cell proliferation. Further toxicity assays in vivo indicated that mutants SEC2-H118A and SEC2-H122A were defective in emetic and febrile activities. However, mutant SEC2-H47A could cause significant emetic and febrile responses in comparison with the other two histidine mutants. These findings suggested that the zinc-coordinating histidine residues play significant roles in superantigen and toxic activities of SEC2 and further implied that superantigen and febrile activities could be separable in staphylococcal enterotoxins. The results also show that it should be possible to design new SEC2 immunotherapeutic agents that have superantigen activity and low toxicity.
细菌毒素葡萄球菌肠毒素C2(SEC2)可导致葡萄球菌中毒性休克综合征和食物中毒。尽管先前测定的SEC2晶体结构显示一些组氨酸残基(His47、His118和His122)有助于锌离子的结合,但它们在SEC2中的生物学作用却知之甚少。这促使我们研究锌结合位点的组氨酸残基在SEC2生物学活性中的作用。在第118位和第122位发生取代的突变体均保留了T细胞刺激活性,而第47位的组氨酸突变体在刺激T细胞增殖的能力上存在缺陷。进一步的体内毒性试验表明,突变体SEC2-H118A和SEC2-H122A在催吐和发热活性方面存在缺陷。然而,与其他两个组氨酸突变体相比,突变体SEC2-H47A可引起显著的催吐和发热反应。这些发现表明,与锌结合的组氨酸残基在SEC2的超抗原和毒性活性中发挥着重要作用,进一步暗示在葡萄球菌肠毒素中超抗原和发热活性可能是可分离的。结果还表明,有可能设计出具有超抗原活性和低毒性的新型SEC2免疫治疗剂。